Comment on “The End of Phase 3 Clinical Trials in Biosimilars Development?”

Detalles Bibliográficos
Autores principales: Webster, Christopher J., Woollett, Gillian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182457/
https://www.ncbi.nlm.nih.gov/pubmed/30117118
http://dx.doi.org/10.1007/s40259-018-0297-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182457/
https://www.ncbi.nlm.nih.gov/pubmed/30117118
http://dx.doi.org/10.1007/s40259-018-0297-y

Ejemplares similares